The correct dose depends on your goal. General health: 1,000–2,000 mg EPA+DHA/day. Elevated triglycerides: 3,000–4,000 mg/day (FDA allows health claims at this dose). Depression/mood: 1,000–2,000 mg EPA-dominant omega-3/day. Anti-inflammatory: 2,000–3,000 mg/day. Joint health: 2,700 mg/day minimum in studies. The critical distinction: doses on fish oil labels often show total fish oil, not EPA+DHA — check the 'Supplement Facts' for actual EPA+DHA content.
Key Facts at a Glance
| General health dose | 1,000–2,000 mg EPA+DHA/day |
| Triglyceride reduction dose | 3,000–4,000 mg EPA+DHA/day |
| FDA's 'no risk' threshold | 3,000 mg/day from supplements |
| Depression (EPA-dominant) | 1,000–2,000 mg EPA/day |
| Key label caveat | Check EPA+DHA, not total fish oil |
| Blood thinning concern | >3g/day — disclose to doctor |
How to Read Omega-3 Labels Correctly
The most common omega-3 confusion: a '1,000 mg fish oil' capsule typically contains only 300 mg of actual EPA+DHA. The rest is other fatty acids. Always look at the 'Supplement Facts' panel for the EPA+DHA amounts specifically — this is what the research doses refer to. A high-quality fish oil may provide 700–900 mg EPA+DHA per capsule, meaning you need fewer capsules for the same benefit.
Omega-3 Dosing by Health Goal
Evidence-based EPA+DHA doses by condition: • General cardiovascular health: 1,000–2,000 mg/day • Elevated triglycerides (clinical): 3,000–4,000 mg/day • Depression and mood support: 1,000–2,000 mg EPA-dominant (EPA:DHA >2:1) • Chronic inflammation and joint pain: 2,000–3,000 mg/day • Rheumatoid arthritis: 2,700+ mg/day (ARA/EULAR dosing studies) • Pregnancy (DHA): 200–300 mg DHA/day minimum for fetal brain development • Athletic recovery: 1,500–2,000 mg/day • Brain health/cognitive protection: 1,000–2,000 mg/day DHA-dominant
EPA vs DHA: Which Matters More?
EPA and DHA have distinct and complementary roles: • EPA: primary anti-inflammatory omega-3. Converts to anti-inflammatory eicosanoids (series 3 prostaglandins). The active component in depression treatment — studies show EPA-dominant formulas (EPA:DHA >2:1 ratio) are most effective for mood. Key for cardiovascular protection. • DHA: structural omega-3. 97% of brain omega-3 is DHA. 93% of retinal omega-3 is DHA. Essential for neuronal membrane function, cognitive performance, fetal brain development, and eye health. For most people: balanced EPA+DHA is appropriate. For depression/mood: emphasise EPA. For brain health/cognition in older adults: emphasise DHA.
Fish Oil Safety and Side Effects
Omega-3 is very safe at recommended doses. At doses above 3 g/day EPA+DHA: mild antiplatelet (blood-thinning) effects — report to physician if taking blood thinners (warfarin, aspirin, clopidogrel). The FDA states 3 g/day from supplements is safe for most adults (up to 5 g/day total from food+supplements). Common side effects: fishy aftertaste and GI upset — resolved with enteric-coated or rTG-form fish oil, and by taking with meals. Rancid fish oil (smell strongly of fish) should be discarded — oxidised oil is counterproductive.
Best Forms of Omega-3 Supplement
Omega-3 bioavailability varies significantly by form: • Re-esterified triglyceride (rTG): highest bioavailability — 70% better absorbed than ethyl ester • Natural triglyceride (TG) form: excellent — naturally occurring in fish • Phospholipid form (krill oil): good bioavailability, contains astaxanthin, but lower EPA+DHA concentration • Ethyl ester (EE): most common pharmaceutical form — adequate but requires fat for absorption • ALA (flaxseed, chia): less than 5% converts to EPA/DHA — not equivalent to marine omega-3
Frequently Asked Questions
Clinical References
- Bhatt DL et al. (2019). N Engl J Med. REDUCE-IT trial — cardiovascular risk reduction with icosapentaenoic acid. → Source
- Sublette ME et al. (2011). J Clin Psychiatry. Efficacy of EPA in major depressive disorder. → Source
- NIH Office of Dietary Supplements. Omega-3 Fatty Acids Fact Sheet. → Source
- FDA. (2019). Qualified Health Claims: Omega-3 Fatty Acids and Reduced Risk of Coronary Heart Disease. → Source